UCB INC FDA Approval NDA 011613

NDA 011613

UCB INC

FDA Drug Application

Application #011613

Documents

Letter2003-10-16
Letter2012-12-11
Label2012-12-07

Application Sponsors

NDA 011613UCB INC

Marketing Status

Discontinued002
Discontinued004

Application Products

002CAPSULE, EXTENDED RELEASE;ORALEQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**0IONAMINPHENTERMINE RESIN COMPLEX
004CAPSULE, EXTENDED RELEASE;ORALEQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**0IONAMINPHENTERMINE RESIN COMPLEX

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1959-05-04PRIORITY
LABELING; LabelingSUPPL6AP1975-04-10
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1978-10-31PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1980-05-02PRIORITY
LABELING; LabelingSUPPL10AP1980-09-25
LABELING; LabelingSUPPL11AP1984-02-07
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1983-04-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1983-06-16PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1985-12-31PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1985-07-23PRIORITY
LABELING; LabelingSUPPL17AP1985-09-04
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1987-05-04PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1987-07-10PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1987-08-03PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL21AP1993-07-08PRIORITY
LABELING; LabelingSUPPL23AP1998-02-27STANDARD
LABELING; LabelingSUPPL24AP1998-02-17STANDARD
LABELING; LabelingSUPPL26AP2003-10-08STANDARD
LABELING; LabelingSUPPL27AP2012-12-05901 REQUIRED

Submissions Property Types

SUPPL8Null0
SUPPL9Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL21Null0
SUPPL27Null7

CDER Filings

UCB INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 11613
            [companyName] => UCB INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"IONAMIN","activeIngredients":"PHENTERMINE RESIN COMPLEX","strength":"EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"IONAMIN","activeIngredients":"PHENTERMINE RESIN COMPLEX","strength":"EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"12\/05\/2012","submission":"SUPPL-27","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/011613s027lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"IONAMIN","submission":"PHENTERMINE RESIN COMPLEX","actionType":"EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"IONAMIN","submission":"PHENTERMINE RESIN COMPLEX","actionType":"EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"CAPSULE, EXTENDED RELEASE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2012-12-05
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.